(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.13%) $0.800
(-0.32%) $91.87
2 days till quarter result
(bmo 2024-04-29)
Expected move: +/- 18.72%
Live Chart Being Loaded With Signals
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States...
Stats | |
---|---|
Today's Volume | 43 732.00 |
Average Volume | 133 020 |
Market Cap | 10.69M |
EPS | $0 ( 2024-03-29 ) |
Next earnings date | ( $0 ) 2024-04-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.430 |
ATR14 | $0.00700 (0.70%) |
Volume Correlation
Bionomics Limited Correlation
10 Most Positive Correlations | |
---|---|
GETVV | 0.97 |
LVTX | 0.951 |
MMAT | 0.946 |
KTTA | 0.944 |
VIH | 0.936 |
OP | 0.936 |
GRNV | 0.935 |
RMRM | 0.934 |
DRUG | 0.932 |
SYBT | 0.932 |
10 Most Negative Correlations | |
---|---|
TIPT | -0.948 |
LYTS | -0.945 |
JMPNZ | -0.94 |
LRFC | -0.938 |
GLLI | -0.934 |
THCP | -0.932 |
NKSH | -0.932 |
WYNN | -0.93 |
LMB | -0.928 |
HAIA | -0.927 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bionomics Limited Correlation - Currency/Commodity
Bionomics Limited Financials
Annual | 2023 |
Revenue: | $432 666 |
Gross Profit: | $-12.63M (-2 919.26 %) |
EPS: | $-2.60 |
FY | 2023 |
Revenue: | $432 666 |
Gross Profit: | $-12.63M (-2 919.26 %) |
EPS: | $-2.60 |
FY | 2022 |
Revenue: | $4.18M |
Gross Profit: | $-6.87M (-164.21 %) |
EPS: | $-2.49 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.50 |
Financial Reports:
No articles found.
Bionomics Limited
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators